An in vivo RNAi therapy screen identifies novel mediators of leukemia-microenvironment interaction
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biology, 2016. === Cataloged from PDF version of thesis. === Includes bibliographical references. === Minimal residual disease refers to those cancer cells that persist following initial therapy. In precursor B-cell acute lymphobla...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | English |
| Published: |
Massachusetts Institute of Technology
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1721.1/103236 |